Verification evidence is still being completed.
PDF / print export
FyoniBio
Heidelberg, Germany
- Verified lead
- Philippe Ulsemer
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Co-Founder and Chief Executive Officer
- 2026 technical specialization
- Biologics Development, Cell Line Engineering, CMC Analytics, and Bioanalytical Support
- Review cycle
- May 2026
- Full address
- Robert-Roessle-Str. 10, 13125 Berlin, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- FyoniBio leadership disclosure.
- Editorial note
- Biologics-development platform bridging cell-line engineering, CMC analytics, and clinical bioanalysis in the Berlin-Buch node.
Biologics Development, Cell Line Engineering, CMC Analytics, and Bioanalytical Support
Biopharma development quality systems, Bioanalytical support platform
Biologics-development platform bridging cell-line engineering, CMC analytics, and clinical bioanalysis in the Berlin-Buch node.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Heidelberg, Germany
FyoniBio
Biologics Development, Cell Line Engineering, CMC Analytics, and Bioanalytical Support · Integrated biologics-development platform
Biologics-development platform bridging cell-line engineering, CMC analytics, and clinical bioanalysis in the Berlin-Buch node.
- Lead
- Philippe Ulsemer (verified ↗)
- Address
- Robert-Roessle-Str. 10, 13125 Berlin, Germany (source ↗)
- Compliance
- GLP
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- Integrated biologics-development platform
- Capabilities
- Cell-line development · Bioanalytical characterization · CMC development support
- Founded
- 2020
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Philippe Ulsemer
Co-Founder and Chief Executive Officer
Full addressRobert-Roessle-Str. 10, 13125 Berlin, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official FyoniBio contact page naming Robert-Roessle-Str. 10, Berlin as the company address.
Open sourceIntegrated biologics-development platform
Heidelberg, Germany. Biologics Development, Cell Line Engineering, CMC Analytics, and Bioanalytical Support. Review completed on 15 Mar 2026.
German and EU biopharma development framework
Biopharma development quality systems, Bioanalytical support platform
Biologics Development, Cell Line Engineering, CMC Analytics, and Bioanalytical Support
Biologics-development platform bridging cell-line engineering, CMC analytics, and clinical bioanalysis in the Berlin-Buch node.
Related companies
Editorial note
FyoniBio strengthens the Berlin-Buch cluster with a specialist biologics-development model positioned between research platforms and manufacturing transfer.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Cell-line development
Bioanalytical characterization
CMC development support
Clinical bioanalysis
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Cell-line development systems
Bioanalytical labs
CMC development infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is FyoniBio located?
- FyoniBio operates from Robert-Roessle-Str. 10, 13125 Berlin, Germany, Heidelberg, Germany.
- Who runs FyoniBio?
- FyoniBio is led by Philippe Ulsemer, Co-Founder and Chief Executive Officer. Verified 15 Mar 2026.
- What does FyoniBio do?
- Biologics-development platform bridging cell-line engineering, CMC analytics, and clinical bioanalysis in the Berlin-Buch node. Core capabilities: Cell-line development, Bioanalytical characterization, CMC development support, Clinical bioanalysis.
Editorial context
Related technical briefs
Briefs that name Heidelberg as a covered market or city.